2025 Top 10 oncology tests Suppliers in China

Introduction to Oncology Tests

Oncology tests play a crucial role in the field of cancer diagnosis, treatment, and prognosis. These tests are designed to detect the presence of cancer, identify specific types of cancer, determine the stage of the disease, and monitor the response to treatment. They can involve various techniques, including genetic testing, biomarker analysis, imaging tests, and histological examinations. With the increasing incidence of cancer worldwide, the demand for accurate and reliable oncology tests has been on the rise. China, with its advanced biotechnology and medical research capabilities, has emerged as a significant player in the global oncology test market, with many domestic suppliers offering high - quality products and services.

Top 10 Oncology Tests Suppliers in China

1. Hangzhou Biotest Biotech Co., Ltd.

Hangzhou Biotest Biotech Co., Ltd. is a leading biotechnology company focusing on in - vitro diagnostic products. The company is committed to developing and manufacturing high - quality diagnostic reagents and instruments. With a team of experienced researchers and a state - of - the - art R & D center, Hangzhou Biotest Biotech has made significant contributions to the field of oncology testing.

Features in Oncology Tests

• Diverse Test Portfolio: The company offers a wide range of oncology tests, including tumor marker detection kits. These kits can detect multiple tumor markers simultaneously, providing comprehensive information for cancer diagnosis and monitoring. For example, their kits can detect markers such as carcinoembryonic antigen (CEA), alpha - fetoprotein (AFP), and cancer antigen 125 (CA125), which are commonly used in the diagnosis of various cancers, including lung cancer, liver cancer, and ovarian cancer.
• High Sensitivity and Specificity: The oncology tests developed by Hangzhou Biotest Biotech are known for their high sensitivity and specificity. This means that they can accurately detect the presence of cancer cells or tumor markers even at low concentrations, while minimizing false - positive and false - negative results. This is crucial for early cancer detection and accurate treatment planning.
• User - friendly Design: The test kits are designed to be user - friendly, with simple operation procedures. This makes them suitable for use in various medical settings, including hospitals, clinics, and research institutions.

Company Advantages

• Strong R & D Capability: The company invests heavily in research and development, continuously improving its test products. It has established long - term partnerships with many domestic and international research institutions, which helps it to keep up with the latest technological trends in oncology testing.
• Quality Control: Hangzhou Biotest Biotech has a strict quality control system in place. All products undergo rigorous testing and validation before being released to the market, ensuring their reliability and accuracy.
• Customer Service: The company provides excellent customer service, offering technical support and training to its customers. This helps users to make the most of their oncology test products.

Website: https://www.biotestrt.com/

2. BGI Genomics Co., Ltd.

BGI Genomics is a world - renowned genomics company with a strong presence in the oncology testing field. It has a vast amount of sequencing data and advanced sequencing technologies, which enable it to offer comprehensive genomic testing services for cancer patients.

Features in Oncology Tests

• Comprehensive Genomic Profiling: BGI Genomics can perform comprehensive genomic profiling of cancer patients, including whole - exome sequencing (WES) and whole - genome sequencing (WGS). These tests can identify genetic mutations, copy number variations, and gene fusions in cancer cells, providing valuable information for personalized cancer treatment. For example, in lung cancer patients, genomic profiling can help identify specific mutations that are targetable by certain drugs, such as epidermal growth factor receptor (EGFR) mutations.
• Liquid Biopsy: The company is also at the forefront of liquid biopsy technology. Liquid biopsy involves analyzing circulating tumor DNA (ctDNA) in the blood, which can provide real - time information about the genetic changes in cancer cells. This non - invasive method is particularly useful for monitoring cancer progression and treatment response, as well as for early cancer detection.
• Big Data Analytics: BGI Genomics has a large - scale genomics database, which allows it to perform in - depth data analysis. By comparing the genomic data of cancer patients with a large reference population, the company can identify novel genetic markers and patterns associated with cancer, which can be used for more accurate diagnosis and prognosis.

Company Advantages

• Global Influence: BGI Genomics has a global network of partners and customers, which gives it access to a large amount of genomic data from different populations. This global perspective helps the company to develop more accurate and applicable oncology tests.
• Advanced Technology Platforms: The company has invested in state - of - the - art sequencing platforms, such as the BGISEQ series. These platforms offer high - throughput, high - accuracy sequencing capabilities, which are essential for large - scale genomic studies and oncology testing.
• Clinical Application Experience: BGI Genomics has extensive experience in applying genomic testing in clinical practice. It has collaborated with many hospitals and research institutions to conduct clinical trials and validation studies, ensuring the clinical utility of its oncology test products.

3. Shanghai Fosun Medical (Group) Co., Ltd.

Shanghai Fosun Medical is a diversified healthcare group that has made significant inroads into the oncology testing market. It integrates R & D, production, and sales of medical products and services, with a focus on providing comprehensive solutions for cancer diagnosis and treatment.

Features in Oncology Tests

• Multimodal Testing Approaches: Fosun Medical offers a combination of different oncology testing methods, including imaging - based tests, biomarker assays, and genetic tests. For example, it provides positron emission tomography - computed tomography (PET - CT) scanners, which can detect cancerous lesions in the body with high precision. In addition, it also offers a range of biomarker detection kits and genetic testing services, allowing for a more comprehensive assessment of cancer patients.
• Personalized Testing Solutions: The company emphasizes personalized medicine in oncology testing. It can customize testing plans according to the specific needs of individual patients, taking into account factors such as the type of cancer, the patient's genetic background, and the stage of the disease. This personalized approach helps to optimize treatment decisions and improve patient outcomes.
• Integration with Treatment Services: Fosun Medical has a strong presence in the cancer treatment field, with a network of hospitals and cancer centers. This allows for seamless integration of oncology testing with treatment services. After obtaining test results, patients can receive timely and appropriate treatment from the company's affiliated medical institutions.

Company Advantages

• Comprehensive Healthcare Ecosystem: The company's diversified business model creates a comprehensive healthcare ecosystem. This ecosystem enables better coordination between different aspects of cancer care, from testing to treatment, which is beneficial for patients and healthcare providers alike.
• Strong Brand Reputation: Fosun Medical has a well - established brand reputation in the healthcare industry. Its products and services are trusted by patients, medical professionals, and regulatory authorities, which gives it a competitive edge in the oncology test market.
• Investment in Innovation: The company continuously invests in research and development to improve its oncology test products and services. It also actively seeks strategic partnerships and acquisitions to expand its technological capabilities and market share.

4. Nanjing Vazyme Biotech Co., Ltd.

Nanjing Vazyme Biotech is a leading provider of molecular biology reagents and solutions, with a particular focus on oncology testing. The company is dedicated to developing innovative technologies and products to meet the growing demand for accurate and efficient cancer diagnosis.

Features in Oncology Tests

• High - Performance PCR - Based Tests: Vazyme Biotech specializes in polymerase chain reaction (PCR) - based oncology tests. Its PCR reagents are known for their high amplification efficiency, sensitivity, and specificity. These tests can be used for detecting genetic mutations, gene expression analysis, and copy number variation detection in cancer cells. For example, the company's PCR - based tests can accurately detect BRAF mutations in melanoma patients, which is important for guiding targeted therapy.
• Customizable Assays: The company offers customizable oncology test assays. It can design and develop specific tests according to the requirements of customers, such as research institutions and pharmaceutical companies. This flexibility allows for the development of tailored solutions for different cancer research and diagnostic needs.
• Automated Testing Systems: Vazyme Biotech has developed automated testing systems that can streamline the oncology testing process. These systems can handle multiple samples simultaneously, reducing the turnaround time and improving the efficiency of testing.

Company Advantages

• Technical Expertise in Molecular Biology: The company has a team of experts in molecular biology, who are well - versed in the latest techniques and technologies in the field. This technical expertise enables the company to develop high - quality oncology test products.
• Cost - Effective Solutions: Vazyme Biotech is committed to providing cost - effective oncology testing solutions. By optimizing its production processes and supply chain management, the company can offer competitive prices without compromising on the quality of its products.
• Rapid Response to Market Needs: The company is known for its ability to quickly respond to market needs. It can develop and launch new oncology test products in a relatively short time, which is crucial in the fast - evolving field of cancer diagnosis.

5. Beijing Hotgen Biotech Co., Ltd.

Beijing Hotgen Biotech is a biotechnology company that focuses on the development and production of in - vitro diagnostic reagents, with a significant emphasis on oncology testing. It aims to provide reliable and innovative solutions for cancer detection and monitoring.

Features in Oncology Tests

• High - Throughput Testing Platforms: Hotgen Biotech has developed high - throughput oncology testing platforms that can analyze a large number of samples simultaneously. These platforms are based on advanced microarray and next - generation sequencing technologies, which enable efficient and comprehensive genetic analysis of cancer cells. For example, the company's platforms can detect multiple genetic mutations in a single test, providing a more complete picture of the genetic landscape of cancer.
• Targeted Therapy - Guiding Tests: The company offers oncology tests that are specifically designed to guide targeted therapy. These tests can identify genetic mutations or biomarkers that are associated with the response to certain targeted drugs. By using these tests, doctors can select the most appropriate targeted therapy for cancer patients, improving treatment efficacy and reducing side effects.
• Clinical Validation: Hotgen Biotech conducts extensive clinical validation studies for its oncology test products. These studies involve collaborating with multiple hospitals and research institutions to evaluate the performance and clinical utility of the tests. This ensures that the tests are reliable and applicable in real - world clinical settings.

Company Advantages

• Proprietary Technologies: The company has developed several proprietary technologies in oncology testing, which give it a competitive advantage in the market. These technologies enable more accurate and efficient testing, as well as the development of unique test products.
• Quality - Driven Approach: Hotgen Biotech adheres to strict quality control standards throughout the entire product development and manufacturing process. This quality - driven approach ensures the reliability and reproducibility of its oncology test products.
• Collaboration with the Medical Community: The company has established strong partnerships with the medical community, including hospitals, research institutions, and pharmaceutical companies. These collaborations help the company to stay updated on the latest clinical needs and to translate research findings into practical oncology test products.

6. Wuhan MGI Tech Co., Ltd.

Wuhan MGI Tech is a leading provider of high - throughput sequencing technologies and solutions, with a growing presence in the oncology testing field. It is committed to making genomics more accessible and affordable for cancer research and diagnosis.

Features in Oncology Tests

• Ultra - High - Throughput Sequencing: MGI Tech's sequencing platforms offer ultra - high - throughput capabilities, which can sequence a large number of cancer genomes in a short time. This high - throughput sequencing is essential for large - scale cancer genomics studies, as well as for clinical oncology testing, where rapid turnaround times are often required.
• Low - Cost Sequencing Solutions: The company focuses on developing low - cost sequencing solutions without sacrificing quality. This makes genomics - based oncology testing more accessible to a wider range of patients and research institutions. For example, its sequencing technologies can significantly reduce the cost of whole - genome sequencing for cancer patients, enabling more comprehensive genetic analysis.
• Integrated Sequencing Workflow: MGI Tech provides an integrated sequencing workflow, which includes sample preparation, sequencing, and data analysis. This integrated approach simplifies the oncology testing process and improves the efficiency and accuracy of sequencing results.

Company Advantages

• Innovative Sequencing Technologies: The company has developed a series of innovative sequencing technologies, such as the DNBSEQ technology. These technologies offer unique advantages in terms of sequencing accuracy, throughput, and cost - effectiveness, which are highly valued in the oncology testing market.
• Global Market Reach: MGI Tech has a global market reach, with its products and services being used in many countries around the world. This global presence allows the company to gain insights from different markets and to adapt its oncology test products to meet the diverse needs of customers.
• Continuous Technological Improvement: The company is constantly investing in research and development to improve its sequencing technologies and oncology test products. It aims to stay at the forefront of the genomics industry and to provide the most advanced solutions for cancer diagnosis and research.

7. Suzhou Abogen Biosciences Co., Ltd.

Suzhou Abogen Biosciences is a biotechnology company that focuses on the development of nucleic acid - based drugs and diagnostic products, including oncology tests. It combines cutting - edge biotechnology with a deep understanding of cancer biology to develop innovative solutions for cancer detection.

Features in Oncology Tests

• mRNA - Based Testing Technologies: Abogen Biosciences is exploring the use of messenger RNA (mRNA) - based technologies in oncology testing. mRNA can provide valuable information about gene expression patterns in cancer cells, which can be used for cancer diagnosis, prognosis, and treatment monitoring. The company's mRNA - based tests can detect specific mRNA molecules associated with cancer, offering a new approach to cancer detection.
• Multiplexed Testing Assays: The company has developed multiplexed oncology testing assays that can detect multiple biomarkers or genetic mutations simultaneously. This multiplexing capability allows for a more comprehensive and efficient assessment of cancer patients, reducing the need for multiple individual tests.
• Early Cancer Detection Focus: Abogen Biosciences places a strong emphasis on early cancer detection. Its oncology test products are designed to detect cancer at an early stage, when treatment is more likely to be successful. By using sensitive and specific detection methods, the company aims to improve the survival rates of cancer patients.

Company Advantages

• Nucleic Acid Expertise: The company has in - depth expertise in nucleic acid research and development. This expertise enables it to develop novel oncology test products based on nucleic acid technologies, which have the potential to revolutionize cancer diagnosis.
• Collaboration with Academic Institutions: Abogen Biosciences collaborates closely with academic institutions to conduct pre - clinical and clinical research. These collaborations help the company to validate its oncology test products and to translate scientific discoveries into practical applications.
• Long - Term Vision for Cancer Care: The company has a long - term vision for improving cancer care. It not only focuses on developing oncology test products but also explores the potential of nucleic acid - based drugs for cancer treatment, aiming to provide a comprehensive solution for cancer patients.

8. Guangzhou Darui Biotechnology Co., Ltd.

Guangzhou Darui Biotechnology is a professional biotechnology company that specializes in the research, development, production, and sales of in - vitro diagnostic reagents, including a wide range of oncology tests. It is committed to providing high - quality and cost - effective diagnostic solutions for the medical community.

Features in Oncology Tests

• Broad Range of Tumor Marker Assays: Darui Biotechnology offers a broad range of tumor marker assays, covering various types of cancer. These assays can detect common tumor markers such as prostate - specific antigen (PSA) for prostate cancer, CA19 - 9 for pancreatic cancer, and human chorionic gonadotropin (hCG) for gestational trophoblastic diseases. The company's tumor marker assays are known for their high accuracy and reliability.
• Automated Testing Systems Compatibility: The company's oncology test reagents are compatible with a variety of automated testing systems. This compatibility allows for seamless integration into existing laboratory workflows, improving the efficiency and productivity of oncology testing in clinical laboratories.
• Continuous Product Innovation: Darui Biotechnology invests in continuous product innovation. It is constantly researching and developing new oncology test products to meet the changing needs of the market. For example, the company is exploring the development of new tumor markers and more sensitive detection methods.

Company Advantages

• Established Production Facilities: The company has well - established production facilities that adhere to strict quality control standards. This ensures the consistent quality of its oncology test products.
• Customer - Centered Service: Darui Biotechnology provides customer - centered service, offering technical support and training to its customers. It also listens to customer feedback and uses it to improve its products and services.
• Competitive Pricing Strategy: The company adopts a competitive pricing strategy, making its oncology test products more accessible to a wider range of customers, including small - and medium - sized hospitals and clinics.

9. Shenzhen New Industries Biomedical Engineering Co., Ltd.

Shenzhen New Industries Biomedical Engineering is a leading enterprise in the field of in - vitro diagnostics, with a significant presence in the oncology testing market. It focuses on developing and manufacturing advanced diagnostic instruments and reagents for cancer diagnosis and monitoring.

Features in Oncology Tests

• Chemiluminescence Immunoassay Technology: The company is well - known for its chemiluminescence immunoassay (CLIA) technology, which is widely used in oncology testing. CLIA offers high sensitivity and specificity, allowing for accurate detection of tumor markers. New Industries Biomedical Engineering's CLIA - based oncology tests can detect a variety of tumor markers with high precision, providing reliable information for cancer diagnosis and treatment.
• Integrated Diagnostic Solutions: The company provides integrated diagnostic solutions for oncology testing, which include diagnostic instruments, reagents, and software. This integrated approach simplifies the testing process and improves the overall efficiency of cancer diagnosis in clinical laboratories.
• Clinical Research - Driven Development: New Industries Biomedical Engineering is driven by clinical research in its product development. It conducts extensive clinical trials to validate the performance and clinical utility of its oncology test products. This ensures that the products are relevant and useful in real - world clinical settings.

Company Advantages

• Advanced Manufacturing Capabilities: The company has advanced manufacturing capabilities, which enable it to produce high - quality oncology test products in large quantities. Its manufacturing facilities are equipped with state - of - the - art production equipment and adhere to strict quality management systems.
• Strong R & D Team: New Industries Biomedical Engineering has a strong R & D team consisting of experts in various fields, such as biochemistry, immunology, and engineering. This team is responsible for the continuous innovation and improvement of the company's oncology test products.
• Market Leadership in CLIA Technology: The company is a market leader in CLIA technology for oncology testing. Its products are widely recognized and used in the domestic and international markets, giving it a competitive edge over other suppliers.

10. Xiamen Zeesan Biotech Co., Ltd.

Xiamen Zeesan Biotech is a biotechnology company that focuses on the development, production, and sales of in - vitro diagnostic products, including oncology tests. It is committed to providing high - quality and innovative diagnostic solutions for the early detection and management of cancer.

Features in Oncology Tests

• Microfluidic - Based Testing Platforms: Zeesan Biotech has developed microfluidic - based oncology testing platforms. Microfluidic technology allows for the miniaturization and automation of oncology tests, reducing the sample volume required and improving the testing efficiency. These platforms can perform multiple tests simultaneously on a single chip, providing a rapid and comprehensive analysis of cancer samples.
• Multi - Parameter Detection: The company's oncology tests are capable of multi - parameter detection. They can measure multiple biomarkers or genetic characteristics in a single test, providing a more comprehensive view of the cancer status. This multi - parameter approach is beneficial for accurate cancer diagnosis, prognosis, and treatment selection.
• Point - of - Care Testing (POCT) Solutions: Zeesan Biotech offers point - of - care testing solutions for oncology. These POCT products are designed to be used at the patient's bedside or in a near - patient setting, providing rapid test results. This is particularly useful in emergency situations or in areas with limited laboratory facilities.

Company Advantages

• Innovative Microfluidic Technology: The company's microfluidic technology is a key advantage. It enables the development of unique oncology test products that are more efficient, accurate, and user - friendly compared to traditional testing methods.
• Flexible Product Development: Zeesan Biotech has the ability to develop flexible oncology test products according to different customer needs. It can customize test panels and platforms, making it suitable for a variety of applications in cancer diagnosis and research.
• Global Market Expansion: The company is actively expanding its global market. It participates in international exhibitions and collaborates with overseas partners, which helps to promote its oncology test products and gain recognition in the global market.

Conclusion

The top 10 oncology test suppliers in China, as presented above, represent the cutting - edge of the country's biotechnology and medical research capabilities in the field of cancer diagnosis. Each company has its own unique features and advantages, whether it is in terms of advanced technologies, comprehensive test portfolios, or strong R & D capabilities. Companies like Hangzhou Biotest Biotech offer user - friendly and reliable tumor marker detection kits, while BGI Genomics leads the way in genomic profiling and liquid biopsy. Shanghai Fosun Medical provides a comprehensive healthcare ecosystem that integrates testing with treatment services.

The diversity of these suppliers ensures that there are a wide range of oncology test options available to meet the different needs of patients, medical professionals, and research institutions. As the demand for oncology tests continues to grow, these companies are likely to play an even more important role in the global fight against cancer. They will not only contribute to the early detection and accurate diagnosis of cancer but also support the development of personalized cancer treatment strategies, ultimately improving the prognosis and quality of life of cancer patients. With continuous innovation and investment in research and development, the future of oncology testing in China looks promising, and these top 1